IDENTIFICATION AND USE OF MIRNAS FOR DIFFERENTIATING MYELOGENOUS LEUKAEMIA CELLS

摘要

The invention relates to the use of nucleic acid miRNA derived molecules for producing a drug for treating a myelogenous leukemia and to a method for identifying therapeutic agents or the efficient combination thereof for inducing the differentiation of myelogenous leukemia cells.